MetaADEDB 2.0 @ LMMD
Binedaline hydrochloride
(LWSDQRSJVPCQRC-UHFFFAOYSA-N)
Structure
SMILES
C[NH+](CCN(n1cc(c2c1cccc2)c1ccccc1)C)C.[Cl-]
Molecular Formula:
C19H24ClN3
Molecular Weight:
329.867
Log P:
-0.9754
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
1
TPSA:
12.61
CAS Number(s):
57647-35-5
Synonym(s)
1.
Binedaline hydrochloride
2.
Unii-wek9fvt37G
External Link(s)
PubChem Compound70485737
42509
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 10US FAERS
2Drug DependenceFAERS: 8US FAERS
3SomnolenceFAERS: 8US FAERS
4VomitingFAERS: 8US FAERS
5DizzinessFAERS: 6US FAERS
6MalaiseFAERS: 6US FAERS
7VertigoFAERS: 6US FAERS
8DeliriumFAERS: 5US FAERS
9Medication ErrorFAERS: 5US FAERS
10AgitationFAERS: 4US FAERS
11Intentional product misuseFAERS: 4US FAERS
12PalpitationsFAERS: 4US FAERS
13PruritusFAERS: 4US FAERS
14TremorFAERS: 4US FAERS
15ConstipationFAERS: 3US FAERS
16DisorientationFAERS: 3US FAERS
17OverdoseFAERS: 3US FAERS
18Accidental overdoseFAERS: 2US FAERS
19Adverse eventFAERS: 2US FAERS
20Cerebral ataxiaFAERS: 2US FAERS
21DehydrationFAERS: 2US FAERS
22Drug ineffectiveFAERS: 2US FAERS
23DysarthriaFAERS: 2US FAERS
24DysuriaFAERS: 2US FAERS
25General physical health deteriorationFAERS: 2US FAERS
26HyporeflexiaFAERS: 2US FAERS
27IncoherentFAERS: 2US FAERS
28Incorrect dose administeredFAERS: 2US FAERS
29Memory impairmentFAERS: 2US FAERS
30Prescription form tamperingFAERS: 2US FAERS
31Suicide attemptFAERS: 2US FAERS
32TachycardiaFAERS: 2US FAERS
33Visual ImpairmentFAERS: 2US FAERS
34AbasiaFAERS: 1US FAERS
35Abdominal PainFAERS: 1US FAERS
36AngioedemaFAERS: 1US FAERS
37Angle Closure GlaucomaFAERS: 1US FAERS
38AnorexiaFAERS: 1US FAERS
39AnuriaFAERS: 1US FAERS
40AnxietyFAERS: 1US FAERS
41AstheniaFAERS: 1US FAERS
42CataractFAERS: 1US FAERS
43Cerebrovascular accidentFAERS: 1US FAERS
44Chest PainFAERS: 1US FAERS
45CholestasisFAERS: 1US FAERS
46Cold sweatFAERS: 1US FAERS
47Completed SuicideFAERS: 1US FAERS
48DiplopiaFAERS: 1US FAERS
49Drug ToleranceFAERS: 1US FAERS
50Drug abuseFAERS: 1US FAERS
51Drug dispensing errorFAERS: 1US FAERS
52Drug withdrawal syndromeFAERS: 1US FAERS
53ErythemaFAERS: 1US FAERS
54Exposure during breast feedingFAERS: 1US FAERS
55Factor V deficiencyFAERS: 1US FAERS
56HeadacheFAERS: 1US FAERS
57HyperreflexiaFAERS: 1US FAERS
58HypertransaminasaemiaFAERS: 1US FAERS
59HypokinesiaFAERS: 1US FAERS
60HypotensionFAERS: 1US FAERS
61Inappropriate schedule of drug administrationFAERS: 1US FAERS
62InfertilityFAERS: 1US FAERS
63InfluenzaFAERS: 1US FAERS
64MyalgiaFAERS: 1US FAERS
65MyoclonusFAERS: 1US FAERS
66NeutropeniaFAERS: 1US FAERS
67Ocular discomfortFAERS: 1US FAERS
68PallorFAERS: 1US FAERS
69Product quality issueFAERS: 1US FAERS
70Prothrombin time abnormalFAERS: 1US FAERS
71Pulmonary EmbolismFAERS: 1US FAERS
72Renal painFAERS: 1US FAERS
73ShockFAERS: 1US FAERS
74StressFAERS: 1US FAERS
75Sudden onset of sleepFAERS: 1US FAERS
76SyncopeFAERS: 1US FAERS
77ThrombocytopeniaFAERS: 1US FAERS
78Tonic clonic movementsFAERS: 1US FAERS
79UrticariaFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.